1 |
Tablet |
THP1/ OT- ANTIANDROGENS |
THP1/O/T/01 |
Abiraterone acetate tablet |
USP |
250 |
TRUABIRA 250 |
2 |
Tablet |
THP1/ OT- ANTIANDROGENS |
THP1/O/T/02 |
Abiraterone acetate tablet |
USP |
500 |
TRUABIRA 500 |
3 |
Tablet |
THP1/ OT- ANTIANDROGENS |
THP1/O/T/03 |
Bicalutamide tablet |
USP |
50 |
BICATRU 50 |
4 |
Tablet |
THP1/ OT- ANTIANDROGENS |
THP1/O/T/04 |
Bicalutamide tablet |
USP |
150 |
BICATRU 150 |
5 |
Tablet |
THP1/ OT- ANTIANDROGENS |
THP1/O/T/05 |
Flutamide tablet |
USP |
125 |
TRUFLUTA 125 |
6 |
Tablet |
THP1/ OT- ANTIANDROGENS |
THP1/O/T/06 |
Flutamide tablet |
USP |
250 |
TRUFLUTA 250 |
7 |
Tablet |
THP1/ OT- ANTIANDROGENS |
THP1/O/T/07 |
Enzalutamide Tablet |
IH |
40 |
ENZATRU |
8 |
Tablet |
THP2/ OT-NON-STEROIDAL AROMATASE INHIBITRS |
THP2/O/T/01 |
Anastrozole tablet |
USP |
1 |
TRUANA 1 |
9 |
Tablet |
THP2/ OT-NON-STEROIDAL AROMATASE INHIBITRS |
THP2/O/T/02 |
Letrozole tablet |
USP |
2.5 |
TRUTAZ 2.5 |
10 |
Tablet |
THP3/ OT-ANTINEOPLASTIC |
THP3/O/T/01 |
Azacitidine tablet |
IH |
200 |
TRUCITIDINE 200 |
11 |
Tablet |
THP3/ OT-ANTINEOPLASTIC |
THP3/O/T/02 |
Azacitidine tablet |
IH |
300 |
TRUCITIDINE 300 |
12 |
Tablet |
THP3/ OT-ANTINEOPLASTIC |
THP3/O/T/03 |
Capecitabine tablets |
USP |
150 |
TRUCAPS 150 |
13 |
Tablet |
THP3/ OT-ANTINEOPLASTIC |
THP3/O/T/04 |
Capecitabine tablets |
USP |
500 |
TRUCAPS 500 |
14 |
Tablet |
THP3/ OT-ANTINEOPLASTIC |
THP3/O/T/05 |
Methotrexate tablet |
BP |
2.5 |
TRUTEX 2.5 |
15 |
Tablet |
THP4/ OT- IMMUNOSUPPRESSANT |
THP4/O/T/01 |
Azathioprine tablets |
BP |
25 |
AZATRU 25 |
16 |
Tablet |
THP4/ OT- IMMUNOSUPPRESSANT |
THP4/O/T/02 |
Azathioprine tablets |
BP |
50 |
AZATRU 50 |
17 |
Tablet |
THP4/ OT- IMMUNOSUPPRESSANT |
THP4/O/T/03 |
Azathioprine tablets |
BP |
75 |
AZATRU 75 |
18 |
Tablet |
THP4/ OT- IMMUNOSUPPRESSANT |
THP4/O/T/04 |
Azathioprine tablets |
BP |
100 |
AZATRU 100 |
19 |
Tablet |
THP5/ DT-ALKYLATING AGENTS |
THP5/O/T/01 |
Busulphan tablet |
USP |
2 |
TRUBUS 2 |
20 |
Tablet |
THP5/ DT-ALKYLATING AGENTS |
THP5/O/T/02 |
Melphalan tablet |
BP |
2 |
TRUPHALAN 2 |
21 |
Tablet |
THP5/ DT-ALKYLATING AGENTS |
THP5/O/T/03 |
Melphalan tablet |
BP |
5 |
TRUPHALAN 5 |
22 |
Tablet |
THP5/ DT-ALKYLATING AGENTS |
THP5/O/T/04 |
Chlorambucil tablet |
IH |
2 |
TRUBRUCIL 2 |
23 |
Tablet |
THP5/ DT-ALKYLATING AGENTS |
THP5/O/T/05 |
Chlorambucil tablet |
IH |
5 |
TRUBRUCIL 5 |
24 |
Tablet |
THP5/ DT-ALKYLATING AGENTS |
THP5/O/T/06 |
Cyclophosphamide tablet |
USP |
50 |
TRUCYCLO 50 |
25 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/01 |
Dasatinib tablet |
IH |
20 |
TRUDAS 20 |
26 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/02 |
Dasatinib tablet |
IH |
50 |
TRUDAS 50 |
27 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/03 |
Dasatinib tablet |
IH |
70 |
TRUDAS 70 |
28 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/04 |
Dasatinib tablet |
IH |
100 |
TRUDAS 100 |
29 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/05 |
Everolimus tablets |
IH |
0.5 |
EVERTRU 0.5 |
30 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/06 |
Everolimus tablets |
IH |
0.75 |
EVERTRU 0.75 |
31 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/07 |
Everolimus tablets |
IH |
10 |
EVERTRU 10 |
32 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/08 |
Gefitinib tablet |
IH |
250 |
TRUGEF 250 |
33 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/09 |
Ibrutinib tablet |
IH |
140 |
TRUTINIB 140 |
34 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/10 |
Ibrutinib tablet |
IH |
280 |
TRUTINIB 280 |
35 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/11 |
Ibrutinib tablet |
IH |
420 |
TRUTINIB 420 |
36 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/12 |
Ibrutinib tablet |
IH |
560 |
TRUTINIB 560 |
37 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/13 |
Lapatinib Tablets |
IH |
250 |
LAPATRU 250 |
38 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/14 |
Osimertinib tablet |
IH |
40 |
TRUMER 40 |
39 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/15 |
Osimertinib tablet |
IH |
80 |
TRUMER 80 |
40 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/16 |
Axitinib tablet |
IH |
1 |
TRUXITINIB 1 |
41 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/17 |
Axitinib tablet |
IH |
5 |
TRUXITINIB 5 |
42 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/18 |
Palbociclib Tablets |
IH |
125 |
PALBOTRU |
43 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/19 |
Ruxolitinib tablet |
IH |
5 |
TRUXOLI 5 |
44 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/20 |
Ruxolitinib tablet |
IH |
10 |
TRUXOLI 10 |
45 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/21 |
Ruxolitinib tablet |
IH |
15 |
TRUXOLI 15 |
46 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/22 |
Ruxolitinib tablet |
IH |
20 |
TRUXOLI 20 |
47 |
Tablet |
THP6/DT- KINEASE INHIBITORS |
THP6/O/T/23 |
Sorafenib Tablets |
IH |
200 |
TRUSORA 200 |
48 |
Tablet |
THP7/OT-MULTIKINASE INHIBITOR |
THP7/O/T/01 |
Regorafenib Tablets |
IH |
40 |
TRUGORAFENIB 40 |
49 |
Tablet |
THP8/OT- TYROSINE KINASE RECEPTOR INHIBITOR |
THP8/O/T/01 |
Erlotinib tablet |
IH |
25 |
TRUERLO 25 |
50 |
Tablet |
THP8/OT- TYROSINE KINASE RECEPTOR INHIBITOR |
THP8/O/T/02 |
Erlotinib tablet |
IH |
100 |
TRUERLO 100 |
51 |
Tablet |
THP8/OT- TYROSINE KINASE RECEPTOR INHIBITOR |
THP8/O/T/03 |
Erlotinib tablet |
IH |
150 |
TRUERLO 150 |
52 |
Tablet |
THP8/OT- TYROSINE KINASE RECEPTOR INHIBITOR |
THP8/O/T/04 |
Imatinib tablet |
IH |
100 |
TRUMATINIB 100 |
53 |
Tablet |
THP8/OT- TYROSINE KINASE RECEPTOR INHIBITOR |
THP8/O/T/05 |
Imatinib tablet |
IH |
400 |
TRUMATINIB 400 |
54 |
Tablet |
THP9/OT- AROMATASE INHIBITOR |
THP9/O/T/01 |
Exemestane tablet |
IH |
25 |
TRUMESTANE 25 |
55 |
Tablet |
THP10/OT- CHEMOTHERAPY |
THP10/O/T/01 |
Fludarabine Phosphate tablet |
IH |
10 |
FLUDATRU 10 |
56 |
Tablet |
THP11/OT- BISPHOSPHONATES |
THP11/O/T/01 |
Ibadronic acid tablet |
IH |
50 |
TRUDRONIC 50 |
57 |
Tablet |
THP12/OT- PURINE ANTAGONISTS |
THP12/O/T/01 |
Mercaptopurine tablet |
BP |
50 |
TRUPURINE 50 |
58 |
Tablet |
THP13/OT-ANTIESTROGENS |
THP13/O/T/01 |
Tamoxifen tablet |
BP |
10 |
TRUTAM 10 |
59 |
Tablet |
THP13/OT-ANTIESTROGENS |
THP13/O/T/02 |
Tamoxifen tablet |
BP |
20 |
TRUTAM 20 |
60 |
Tablet |
THP14/OT-PURINE ANALOGUES |
THP14/O/T/01 |
Thioguanine tablet |
USP |
40 |
TRUTHIO 40 |
61 |
Tablet |
THP15/OT-5-ALPHA REDUCTASE INHIBITORS |
THP15/O/T/01 |
Finasteride tablet |
USP |
1 |
TRUNASTERIDE 1 |
62 |
Tablet |
THP15/OT-5-ALPHA REDUCTASE INHIBITORS |
THP15/O/T/02 |
Finasteride tablet |
USP |
5 |
TRUNASTERIDE 5 |
63 |
Tablet |
THP16/OT-POLYMERASE INHIBITORS |
THP16/O/T/01 |
Olaparib tablet |
IH |
100 |
TRULAPAR 100 |
64 |
Capsule |
THP1/OC- IMMUNOSUPPRESSANT |
THP1/O/C/01 |
Cyclosporine capsule |
USP |
25 |
TRUSPORIN 25 |
65 |
Capsule |
THP1/OC- IMMUNOSUPPRESSANT |
THP1/O/C/02 |
Cyclosporine capsule |
USP |
50 |
TRUSPORIN 50 |
66 |
Capsule |
THP1/OC- IMMUNOSUPPRESSANT |
THP1/O/C/03 |
Cyclosporine capsule |
USP |
100 |
TRUSPORIN 100 |
67 |
Capsule |
THP2/OC-ALKYLATING AGENTS |
THP2/O/C/01 |
Procarbazine Hydrochloride capsule |
USP |
50 |
TRUCARZINE |
68 |
Capsule |
THP2/OC-ALKYLATING AGENTS |
THP2/O/C/02 |
Temozolomide capsule |
USP |
5 |
TRUTEMO 5 |
69 |
Capsule |
THP2/OC-ALKYLATING AGENTS |
THP2/O/C/03 |
Temozolomide capsule |
USP |
20 |
TRUTEMO 20 |
70 |
Capsule |
THP2/OC-ALKYLATING AGENTS |
THP2/O/C/04 |
Temozolomide capsule |
USP |
100 |
TRUTEMO 100 |
71 |
Capsule |
THP2/OC-ALKYLATING AGENTS |
THP2/O/C/05 |
Temozolomide capsule |
USP |
140 |
TRUTEMO 140 |
72 |
Capsule |
THP2/OC-ALKYLATING AGENTS |
THP2/O/C/06 |
Temozolomide capsule |
USP |
180 |
TRUTEMO 180 |
73 |
Capsule |
THP2/OC-ALKYLATING AGENTS |
THP2/O/C/07 |
Temozolomide capsule |
USP |
250 |
TRUTEMO 250 |
74 |
Capsule |
THP2/OC-ALKYLATING AGENTS |
THP2/O/C/08 |
Cyclophosphamide capsule |
USP |
50 |
TRUCYCLO 50 |
75 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/01 |
Nilotinib capsule |
IH |
150 |
TRUNILO 150 |
76 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/02 |
Nilotinib capsule |
IH |
200 |
TRUNILO 200 |
77 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/03 |
Sunitinib capsule |
IH |
12.5 |
TRUSUNIB 12.5 |
78 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/04 |
Sunitinib capsule |
IH |
25 |
TRUSUNIB 25 |
79 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/05 |
Sunitinib capsule |
IH |
50 |
TRUSUNIB 50 |
80 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/06 |
Ibrutinib capsule |
IH |
70 |
TRUBRU 70 |
81 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/07 |
Ibrutinib capsule |
IH |
140 |
TRUBRU 140 |
82 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/08 |
Lenvatinib capsule |
IH |
4 |
TRUNVATINIB 4 |
83 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/09 |
Lenvatinib capsule |
IH |
10 |
TRUNVATINIB 10 |
84 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/10 |
Palbociclib capsule |
IH |
125 |
PALBOTRU 125 |
85 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/11 |
Estramustine Phosphate capsule |
BP |
140 |
TRUTRAMAS 140 |
86 |
Capsule |
THP3/OC-KINASE INHIBITORS |
THP3/O/C/12 |
Imatinib capsule |
IH |
100 |
TRUMATINIB C 100 |
87 |
Capsule |
THP4/OC-IMMUNOMODULATOR |
THP4/O/C/01 |
Lenalidomide Capsules |
IH |
5 |
TRUNALID 5 |
88 |
Capsule |
THP4/OC-IMMUNOMODULATOR |
THP4/O/C/02 |
Lenalidomide Capsules |
IH |
10 |
TRUNALID 10 |
89 |
Capsule |
THP4/OC-IMMUNOMODULATOR |
THP4/O/C/03 |
Lenalidomide Capsules |
IH |
15 |
TRUNALID 15 |
90 |
Capsule |
THP4/OC-IMMUNOMODULATOR |
THP4/O/C/04 |
Lenalidomide Capsules |
IH |
25 |
TRUNALID 25 |
91 |
Capsule |
THP4/OC-IMMUNOMODULATOR |
THP4/O/C/05 |
Thalidomide capsule |
USP |
50 |
TRUTHALI 50 |
92 |
Capsule |
THP4/OC-IMMUNOMODULATOR |
THP4/O/C/06 |
Thalidomide capsule |
USP |
100 |
TRUTHALI 100 |
93 |
Capsule |
THP5/OC-TOPOISOMERASE II INHIBITOR |
THP5/O/C/01 |
Etoposide capsule |
BP |
50 |
TRUPOSIDE 50 |
94 |
Capsule |
THP5/OC-TOPOISOMERASE II INHIBITOR |
THP5/O/C/02 |
Etoposide capsule |
BP |
100 |
TRUPOSIDE 100 |
95 |
Capsule |
THP6/OC-ANTIMETABOLITE |
THP6/O/C/01 |
Hydroxyurea capsule |
USP |
100 |
TRUUREA 100 |
96 |
Capsule |
THP6/OC-ANTIMETABOLITE |
THP6/O/C/02 |
Hydroxyurea capsule |
USP |
500 |
TRUUREA 500 |
97 |
Capsule |
THP7/OC-ANDROGEN RECEPTOR INHIBITORS |
THP7/O/C/01 |
Enzalutamide capsule |
IH |
40 |
ENZATRU C 40 |
98 |
Injectable (Vial) |
THP1/OIV-CYTOTOXIC CHEMOTHERAPY |
THP1/O/V/01 |
Bleomycin for Injection |
USP |
15 Units |
TRUBLEO |
99 |
Injectable (Vial) |
THP2/OIV-ANTIMETABOLITES |
THP2/O/V/01 |
5- Fluorouracil Injection |
USP |
250 mg / 5ml |
TRUURACIL 250 |
100 |
Injectable (Vial) |
THP2/OIV-ANTIMETABOLITES |
THP2/O/V/02 |
5- Fluorouracil Injection |
USP |
500 mg / 10ml |
TRUURACIL 500 |
101 |
Injectable (Vial) |
THP3/OIV-ANTINEOPLASTIC, PLATINUM ANALOGS |
THP3/O/V/01 |
Cabazitaxel for injection |
USP |
60mg/ 1.5ml |
TRUTAXEL |
102 |
Injectable (Vial) |
THP3/OIV-ANTINEOPLASTIC, PLATINUM ANALOGS |
THP3/O/V/02 |
Carboplatin injection |
BP |
150 mg/ 15 ml |
TRUPLATIN 150 |
103 |
Injectable (Vial) |
THP3/OIV-ANTINEOPLASTIC, PLATINUM ANALOGS |
THP3/O/V/03 |
Carboplatin injection |
BP |
450 mg/ 45 ml |
TRUPLATIN 450 |
104 |
Injectable (Vial) |
THP4/OIV-ALKYLATING AGENT |
THP4/O/V/01 |
Bendamustine for injection |
|
25 mg(100mg/ 4ml) |
BENDATRU |
105 |
Injectable (Vial) |
THP4/OIV-ALKYLATING AGENT |
THP4/O/V/02 |
Cisplatin Injection |
BP |
1mg(10mg/10ml) |
TRUCIS 1 |
106 |
Injectable (Vial) |
THP4/OIV-ALKYLATING AGENT |
THP4/O/V/03 |
Cisplatin Injection |
BP |
10mg(10ml fill) |
TRUCIS 10 |
107 |
Injectable (Vial) |
THP4/OIV-ALKYLATING AGENT |
THP4/O/V/04 |
Cisplatin Injection |
BP |
50mg(50 ml fill) |
TRUCIS 50 |
108 |
Injectable (Vial) |
THP4/OIV-ALKYLATING AGENT |
THP4/O/V/05 |
Cisplatin Injection |
BP |
150mg(15ml fill) |
TRUCIS 150 |
109 |
Injectable (Vial) |
THP4/OIV-ALKYLATING AGENT |
THP4/O/V/06 |
Cisplatin Injection |
BP |
450mg(45ml fill) |
TRUCIS 450 |
110 |
Injectable (Vial) |
THP4/OIV-ALKYLATING AGENT |
THP4/O/V/07 |
Cisplatin Injection |
BP |
10 mg / 10 ml |
TRUCIS 10 |
111 |
Injectable (Vial) |
THP4/OIV-ALKYLATING AGENT |
THP4/O/V/08 |
Cisplatin Injection |
BP |
50 mg / 50ml |
TRUCIS 50 |
112 |
Injectable (Vial) |
THP5/OIV-TAXOID ANTINEOPLASTIC AGENT |
THP5/O/V/01 |
Docetaxel Concentrate Injection |
USP |
20 mg / 0.5 ml |
TRUDOCE 20 |
113 |
Injectable (Vial) |
THP5/OIV-TAXOID ANTINEOPLASTIC AGENT |
THP5/O/V/02 |
Docetaxel Concentrate Injection |
USP |
80 mg / 2 ml |
TRUDOCE 80 |
114 |
Injectable (Vial) |
THP5/OIV-TAXOID ANTINEOPLASTIC AGENT |
THP5/O/V/03 |
Docetaxel Concentrate Injection |
USP |
120 mg / 3 ml |
TRUDOCE 120 |
115 |
Injectable (Vial) |
THP5/OIV-TAXOID ANTINEOPLASTIC AGENT |
THP5/O/V/04 |
Docetaxel Concentrate Injection |
USP |
40mg/2ml |
TRUDOCE 40 |
116 |
Injectable (Vial) |
THP5/OIV-TAXOID ANTINEOPLASTIC AGENT |
THP5/O/V/05 |
Docetaxel Concentrate Injection |
USP |
90mg/4ml |
TRUDOCE 90 |
117 |
Injectable (Vial) |
THP5/OIV-TAXOID ANTINEOPLASTIC AGENT |
THP5/O/V/06 |
Docetaxel Concentrate Injection |
USP |
160mg/8ml |
TRUDOCE 160 |
118 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/01 |
Doxorubicin Hydrochloride for Injection |
USP |
10 mg / 5 ml |
TRURUBICIN 10 |
119 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/02 |
Doxorubicin Hydrochloride for Injection |
USP |
50 mg / 25 ml |
TRURUBICIN 50 |
120 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/03 |
Paclitaxel Injection |
USP |
300 mg / 50ml |
PALCITRU 300/50 |
121 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/04 |
Paclitaxel Injection |
USP |
6mg/ml(16.7ml) |
PALCITRU 6/16.7 |
122 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/05 |
Paclitaxel Injection |
USP |
6mg(260mg/43.3ml) |
PALCITRU 260/43.3 |
123 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/06 |
Paclitaxel Injection |
USP |
6 mg/ml(5ml) |
PALCITRU 6/5 |
124 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/07 |
Paclitaxel Injection |
USP |
6 mg/ml(50 ml) |
PALCITRU 6/50 |
125 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/08 |
Paclitaxel Injection |
USP |
6mg(300mg/50ml) |
PALCITRU 300/50 |
126 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/09 |
Paclitaxel Injection |
USP |
6mg(30mg/5ml) |
PALCITRU 30/5 |
127 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/10 |
Paclitaxel Injection |
USP |
6mg(100mg/16.7ml) |
PALCITRU 100/16.7 |
128 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/11 |
Paclitaxel Injection |
USP |
6mg(300mg/50ml) |
PALCITRU 300/50 |
129 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/12 |
Paclitaxel Injection |
USP |
30 mg / 5 ml |
PALCITRU 30/5 |
130 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/13 |
Paclitaxel Injection |
USP |
100 mg / 16.7 ml |
PALCITRU 100/16.7 |
131 |
Injectable (Vial) |
THP6/OIV-CHEMOTHERAPEUTIC AGENTS |
THP6/O/V/14 |
Paclitaxel Injection |
USP |
260 mg / 43.33 ml |
PALCITRU 260/43.3 |
132 |
Injectable (Vial) |
THP7/OIV- TOPOISOMERASE II INHIBITOR |
THP7/O/V/01 |
Etoposide Injection |
USP |
100 mg / 5ml |
TRUPOSIDE 100/5 |
133 |
Injectable (Vial) |
THP8/OIV-PURINE ANALOGS |
THP8/O/V/01 |
Fludarabine Phosphate for Injection |
USP |
50 mg / 2 ml |
TRUDARABINE 50/2 |
134 |
Injectable (Vial) |
THP9/OIV-5-HT, RECEPTOR ANTAGONISTS |
THP9/O/V/01 |
Granisetron Hydrochloride Injection |
USP |
1 mg / ml |
TRUGRANI 1/1 |
135 |
Injectable (Vial) |
THP9/OIV-5-HT, RECEPTOR ANTAGONISTS |
THP9/O/V/02 |
Granisetron Hydrochloride Injection |
USP |
2 mg / 2ml |
TRUGRANI 2/2 |
136 |
Injectable (Vial) |
THP9/OIV-5-HT, RECEPTOR ANTAGONISTS |
THP9/O/V/03 |
Granisetron Hydrochloride Injection |
USP |
3 mg / 3 ml |
TRUGRANI 3/3 |
137 |
Injectable (Vial) |
THP10/OIV-BISPHOSPHONATE |
THP10/O/V/01 |
Ibandronic Acid Injection |
USP |
3 mg / 3 ml |
TRUDRONIC 3/3 |
138 |
Injectable (Vial) |
THP10/OIV-BISPHOSPHONATE |
THP10/O/V/02 |
Ibandronic Acid Injection |
USP |
6 mg / 6 ml |
TRUDRONIC 6/6 |
139 |
Injectable (Vial) |
THP11/OIV-TOPOISOMERASE I INHIBITORS |
THP11/O/V/01 |
Irinotecan hcl Injection |
USP |
20mg (40mg/2ml) |
TRURINO 40/2 |
140 |
Injectable (Vial) |
THP11/OIV-TOPOISOMERASE I INHIBITORS |
THP11/O/V/02 |
Irinotecan hcl Injection |
USP |
20mg (100mg/5ml) |
TRURINO 100/5 |
141 |
Injectable (Vial) |
THP11/OIV-TOPOISOMERASE I INHIBITORS |
THP11/O/V/03 |
Irinotecan hcl Injection |
USP |
20mg (300mg/15ml) |
TRURINO 300/15 |
142 |
Injectable (Vial) |
THP12/OIV- ANTINEOPLASTIC |
THP12/O/V/01 |
Methotrexate Injection |
BP |
50 mg / 2 ml |
METHOTRU 50/2 |
143 |
Injectable (Vial) |
THP12/OIV- ANTINEOPLASTIC |
THP12/O/V/02 |
Methotrexate Injection |
BP |
500 mg / 20 ml |
METHOTRU 500/20 |
144 |
Injectable (Vial) |
THP12/OIV- ANTINEOPLASTIC |
THP12/O/V/03 |
Methotrexate Injection |
BP |
1000 mg / 40 ml |
METHOTRU 1000/40 |
145 |
Injectable (Vial) |
THP13/OIV- PLATINUM-BASED CHEMOTHERAPEUTIC |
THP13/O/V/01 |
Oxaliplatin Injection |
BP |
50 mg/ 10 ml |
TRUOXALI 50/10 |
146 |
Injectable (Vial) |
THP13/OIV- PLATINUM-BASED CHEMOTHERAPEUTIC |
THP13/O/V/02 |
Oxaliplatin Injection |
USP |
100 mg / 20 ml |
TRUOXALI 100/20 |
147 |
Injectable (Vial) |
THP13/OIV- PLATINUM-BASED CHEMOTHERAPEUTIC |
THP13/O/V/03 |
Oxaliplatin Injection |
USP |
200 mg / 40ml |
TRUOXALI 200/40 |
148 |
Injectable (Vial) |
THP14/OIV-ANTIRESORPTIVE |
THP14/O/V/01 |
Zoledronic Acid Injection |
USP |
4 mg / 5ml |
TRUZOLE 4/5 |
149 |
Injectable (Vial) |
THP14/OIV-ANTIRESORPTIVE |
THP14/O/V/02 |
Zoledronic Acid Injection |
USP |
5mg / 100 ml |
TRUZOLE 5/100 |
150 |
Injectable (Ampoule) |
THP1/OIA-ANTIMETABOLITES |
THP1/O/A/01 |
5- Fluorouracil Injection |
USP |
250 mg / 5ml |
TRUURACIL A 250 |
151 |
Injectable (Ampoule) |
THP1/OIA-ANTIMETABOLITES |
THP1/O/A/02 |
5- Fluorouracil Injection |
USP |
500 mg / 10 ml |
TRUURACIL A 500 |
152 |
Injectable (Ampoule) |
THP1/OIA-5-HT3 RECEPTOR ANTAGONISTS |
THP2/O/A/01 |
Granisetron Hydrochloride Injection |
USP |
1 mg / ml |
TRUGRANI A 1 |
153 |
Injectable (Ampoule) |
THP1/OIA-5-HT3 RECEPTOR ANTAGONISTS |
THP2/O/A/02 |
Granisetron Hydrochloride Injection |
USP |
2 mg / 2ml |
TRUGRANI A 2 |
154 |
Injectable (Ampoule) |
THP1/OIA-5-HT3 RECEPTOR ANTAGONISTS |
THP2/O/A/03 |
Granisetron Hydrochloride Injection |
USP |
3 mg / 3 ml |
TRUGRANI A 3 |
155 |
Injectable (Ampoule) |
THP3/OIA-ANTINEOPLASTIC |
THP3/O/A/01 |
Methotrexate Injection |
BP |
50 mg / 2 ml |
TRUMETHO A 50 |
156 |
Injectable (Lyophilized) |
THP1/OIL ANTINEOPLASTIC |
THP1/O/L/01 |
Azacitidine for Injection (lyo) |
IH |
100ml |
TRUCTIDINE L-100 |
157 |
Injectable (Lyophilized) |
THP1/OIL ANTINEOPLASTIC |
THP1/O/L/02 |
Bortezomib powder for solution injection |
IH |
2.5 mg |
TRUCTIDINE L-2.5 |
158 |
Injectable (Lyophilized) |
THP1/OIL ANTINEOPLASTIC |
THP1/O/L/03 |
Bortezomib powder for solution injection |
IH |
3 mg |
BARTETRU L-3 |
159 |
Injectable (Lyophilized) |
THP1/OIL ANTINEOPLASTIC |
THP1/O/L/04 |
Bortezomib powder for solution injection |
IH |
3.5 mg |
BARTETRU L-3.5 |
160 |
Injectable (Lyophilized) |
THP1/OIL ANTINEOPLASTIC |
THP1/O/L/05 |
Pemetrexed for Injection |
USP |
100 mg / Vial |
TRUEXED L-100 |
161 |
Injectable (Lyophilized) |
THP1/OIL ANTINEOPLASTIC |
THP1/O/L/06 |
Pemetrexed for Injection |
USP |
500 mg / Vial |
TRUEXED L-500 |
162 |
Injectable (Lyophilized) |
THP2/OIL-ANTHRACYCLINE CYTOTOXIC |
THP2/O/L/01 |
Epirubicin Hydrochloride for Injection |
USP |
10 mg / Vial |
EPITRU L-10 |
163 |
Injectable (Lyophilized) |
THP2/OIL-ANTHRACYCLINE CYTOTOXIC |
THP2/O/L/02 |
Epirubicin Hydrochloride for Injection |
USP |
50 mg / Vial |
EPITRU L-50 |
164 |
Injectable (Lyophilized) |
THP3/OIL-ANTIMETABOLITES |
THP3/O/L/01 |
Gemcitabine Hydrochloride for Injection |
USP |
200 mg / Vial |
TRUGEM L-200 |
165 |
Injectable (Lyophilized) |
THP3/OIL-ANTIMETABOLITES |
THP3/O/L/02 |
Gemcitabine Hydrochloride for Injection |
USP |
1000 mg / Vial |
TRUGEM L-1000 |
166 |
Injectable (Lyophilized) |
THP4/OIL-ALKYLATING AGENTS |
THP4/O/L/01 |
Melphalan Injection |
USP |
50 mg |
TRUPHALAN L-50 |
167 |
Injectable (Lyophilized) |
THP4/OIL-ALKYLATING AGENTS |
THP4/O/L/02 |
Bendamustin for injection |
USP |
100mg |
TRUBENDA L-100 |
168 |
Injectable (Lyophilized) |
THP4/OIL-ALKYLATING AGENTS |
THP4/O/L/03 |
Zoledronic Acid For Injection |
USP |
4 mg / Vial |
TRUZOLE L-4 |